US Patent 11433132 Polyomavirus neutralizing antibodies
Patent 11433132 was granted and assigned to Novartis on September, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 28, 2018
Date of Patent
September 6, 2022
Patent Applicant
Patent Application Number
16768429
Patent Inventor Names
Johanna Abend
0
Vanessa Cornacchione
0
John Michael Lindner
0
Elisabetta Traggiai
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11433132 Polyomavirus neutralizing antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
